AMN Healthcare Services (AMN) Financials

$19.06 -0.68 (-3.44%)

As of 03:03 PM Eastern

Annual Income Statements for AMN Healthcare Services

This table shows AMN Healthcare Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	33	82	106	132	142	114	71	327	443	211	-147
Consolidated Net Income / (Loss)	33	82	106	133	142	114	71	327	444	211	-147
Net Income / (Loss) Continuing Operations	33	82	106	133	142	114	71	327	444	211	-147
Total Pre-Tax Income	59	121	176	193	187	148	92	444	607	284	-173
Total Operating Income	68	129	192	212	203	177	149	478	647	338	-103
Total Gross Profit	316	469	620	644	696	743	792	1,310	1,717	1,250	919
Total Revenue	1,036	1,463	1,902	1,988	2,136	2,222	2,394	3,984	5,243	3,789	2,984
Operating Revenue	1,036	1,463	1,902	1,988	2,136	2,222	2,394	3,984	5,243	3,789	2,984
Total Cost of Revenue	720	994	1,283	1,344	1,440	1,479	1,602	2,675	3,527	2,540	2,064
Operating Cost of Revenue	720	994	1,283	1,344	1,440	1,479	1,602	2,675	3,527	2,540	2,064
Total Operating Expenses	248	340	428	432	494	567	643	832	1,070	911	1,022
Selling, General & Admin Expense	232	320	398	400	452	508	550	730	937	756	632
Depreciation Expense	16	21	30	32	41	59	93	101	133	155	167
Impairment Charge	-	-	-	-	-	-	-	-	0.00	0.00	222
Total Other Income / (Expense), net	-9.24	-7.79	-15	-20	-16	-28	-58	-34	-40	-54	-70
Interest Expense	9.24	7.79	15	20	16	28	58	34	40	54	70
Income Tax Expense	25	39	70	60	45	35	21	117	163	74	-26
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-0.14	-0.17	-0.10	0.11	-0.26	-0.00	0.11	0.34	0.64	-0.52	-0.41
Basic Earnings per Share	$0.71	$1.72	$2.21	$2.77	$2.99	$2.44	$1.49	$6.87	$9.96	$5.38	($3.85)
Weighted Average Basic Shares Outstanding	46.50M	47.53M	47.95M	47.81M	47.37M	46.70M	47.42M	47.69M	44.59M	39.17M	38.19M
Diluted Earnings per Share	$0.69	$1.68	$2.15	$2.68	$2.91	$2.40	$1.48	$6.81	$9.90	$5.36	($3.85)
Weighted Average Diluted Shares Outstanding	48.09M	48.84M	49.27M	49.43M	48.67M	47.59M	47.69M	48.05M	44.87M	39.34M	38.19M
Weighted Average Basic & Diluted Shares Outstanding	46.50M	47.53M	47.95M	47.81M	47.40M	46.85M	47.42M	47.69M	44.59M	37.89M	38.19M

This table shows AMN Healthcare Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	92	82	84	61	53	13	17	16	7.09	-187
Consolidated Net Income / (Loss)	92	82	84	61	53	12	17	16	6.99	-188
Net Income / (Loss) Continuing Operations	92	82	84	61	53	12	17	16	6.99	-188
Total Pre-Tax Income	127	107	115	79	75	14	23	22	7.81	-226
Total Operating Income	136	119	126	92	87	34	40	38	22	-203
Total Gross Profit	385	375	369	330	290	261	258	230	213	219
Total Revenue	1,139	1,126	1,126	991	853	818	821	741	688	735
Operating Revenue	1,139	1,126	1,126	991	853	818	821	741	688	735
Total Cost of Revenue	754	750	757	661	564	557	563	511	474	516
Operating Cost of Revenue	754	750	757	661	564	557	563	511	474	516
Total Operating Expenses	249	256	243	239	203	227	218	192	191	422
Selling, General & Admin Expense	215	219	206	202	163	185	175	149	150	159
Depreciation Expense	33	37	38	37	39	41	43	43	41	40
Total Other Income / (Expense), net	-8.96	-12	-10	-12	-12	-20	-17	-16	-14	-23
Interest Expense	8.96	12	10	12	12	20	17	16	14	23
Income Tax Expense	35	26	31	19	22	1.52	5.99	5.73	0.82	-38
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	0.22	-0.15	-0.15	-0.05	-0.13	-0.19	-0.08	-0.18	-0.10	-0.05
Basic Earnings per Share	$2.11	$1.96	$2.03	$1.56	$1.39	$0.40	$0.45	$0.43	$0.18	($4.91)
Weighted Average Basic Shares Outstanding	43.79M	44.59M	41.38M	39.15M	38.15M	39.17M	38.11M	38.17M	38.20M	38.19M
Diluted Earnings per Share	$2.10	$1.94	$2.02	$1.55	$1.39	$0.40	$0.45	$0.42	$0.18	($4.90)
Weighted Average Diluted Shares Outstanding	44.04M	44.87M	41.57M	39.34M	38.33M	39.34M	38.20M	38.23M	38.29M	38.19M
Weighted Average Basic & Diluted Shares Outstanding	43.34M	44.59M	39.65M	37.99M	37.79M	37.89M	38.00M	38.00M	38.07M	38.19M

This table details how cash moves in and out of AMN Healthcare Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-2.51	-3.50	2.11	48	-15	70	-70	163	-109	-30	-19
Net Cash From Operating Activities	28	56	134	161	227	225	257	305	654	372	320
Net Cash From Continuing Operating Activities	28	56	134	161	227	225	257	305	654	372	320
Net Income / (Loss) Continuing Operations	33	82	106	133	142	114	71	327	444	211	-147
Consolidated Net Income / (Loss)	33	82	106	133	142	114	71	327	444	211	-147
Depreciation Expense	16	21	30	32	41	59	94	104	137	161	174
Non-Cash Adjustments To Reconcile Net Income	4.12	-11	24	31	6.54	3.09	40	-131	72	212	306
Changes in Operating Assets and Liabilities, net	-26	-36	-26	-35	38	50	52	5.60	0.90	-212	-12
Net Cash From Investing Activities	-28	-116	-258	-35	-279	-292	-538	-107	-171	-412	-80
Net Cash From Continuing Investing Activities	-28	-116	-258	-35	-279	-292	-538	-107	-171	-412	-80
Purchase of Property, Plant & Equipment	-19	-27	-22	-27	-35	-35	-38	-54	-76	-104	-81
Acquisitions	-19	-86	-218	-3.50	-225	-249	-478	-41	-75	-294	0.00
Purchase of Investments	0.00	0.00	-13	-15	-34	-26	-48	-61	-13	0.00	-1.38
Divestitures	-	-	-	-	0.00	0.00	0.07	-	0.00	0.00	1.65
Sale and/or Maturity of Investments	0.00	0.00	2.00	20	25	32	33	58	14	9.97	9.10
Other Investing Activities, net	10	-3.00	-6.91	-11	-11	-13	-7.66	-8.99	-22	-25	-8.41
Net Cash From Financing Activities	-2.10	56	126	-77	38	137	211	-35	-592	11	-259
Net Cash From Continuing Financing Activities	-2.10	56	126	-77	38	137	211	-35	-592	11	-259
Repayment of Debt	-199	-33	-381	-44	-77	-376	-818	-92	0.00	-359	-376
Repurchase of Common Equity	0.00	0.00	-13	-20	-67	-19	0.00	-2.69	-577	-425	0.00
Issuance of Debt	198	90	524	0.00	195	551	1,047	70	0.00	815	125
Other Financing Activities, net	-2.63	-4.46	-3.57	-13	-13	-19	-18	-10	-15	-21	-8.48
Cash Interest Paid	4.60	5.81	8.06	18	21	24	23	38	38	48	61
Cash Income Taxes Paid	18	33	73	74	31	38	46	106	214	78	28

This table details how cash moves in and out of AMN Healthcare Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	78	-84	-33	-28	33	-1.37	21	-2.93	-16	-21
Net Cash From Operating Activities	114	115	43	198	172	-41	81	100	67	73
Net Cash From Continuing Operating Activities	114	115	43	198	172	-41	81	100	67	73
Net Income / (Loss) Continuing Operations	92	82	84	61	53	12	17	16	6.99	-188
Consolidated Net Income / (Loss)	92	82	84	61	53	12	17	16	6.99	-188
Depreciation Expense	34	38	39	38	41	43	45	45	43	41
Non-Cash Adjustments To Reconcile Net Income	7.72	33	30	117	-2.76	68	28	30	16	232
Changes in Operating Assets and Liabilities, net	-21	-37	-110	-19	81	-164	-8.20	8.59	0.26	-13
Net Cash From Investing Activities	-32	-23	-32	-22	-34	-324	-21	-22	-22	-14
Net Cash From Continuing Investing Activities	-32	-23	-32	-22	-34	-324	-21	-22	-22	-14
Purchase of Property, Plant & Equipment	-20	-25	-17	-26	-30	-30	-18	-27	-19	-16
Acquisitions	-4.03	0.23	-	-	-	-	-	-	-	-1.65
Sale and/or Maturity of Investments	3.46	1.84	2.01	4.98	2.98	-	1.21	3.29	1.21	3.40
Net Cash From Financing Activities	-3.84	-176	-44	-203	-105	363	-39	-80	-60	-80
Net Cash From Continuing Financing Activities	-3.84	-176	-44	-203	-105	363	-39	-80	-60	-80
Repayment of Debt	-	-	-74	-150	-110	-25	-50	-90	-120	-116
Issuance of Debt	-	-	210	200	15	390	15	10	60	40
Other Financing Activities, net	-3.84	-1.47	-6.13	-3.29	-10	-1.21	-3.97	-0.11	-0.47	-3.93
Cash Interest Paid	0.06	19	1.05	22	2.44	23	7.54	25	5.40	23
Cash Income Taxes Paid	44	49	5.40	4.33	1.10	67	4.31	13	4.10	6.48

This table presents AMN Healthcare Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	681	880	1,187	1,254	1,493	1,932	2,354	3,132	2,888	2,924	2,416
Total Current Assets	283	376	451	474	482	560	534	1,349	1,094	842	595
Cash & Equivalents	13	9.58	11	15	14	83	29	181	65	33	11
Accounts Receivable	215	329	391	392	416	425	450	1,029	944	741	508
Prepaid Expenses	10	14	14	17	12	12	14	72	19	22	23
Other Current Assets	17	24	35	51	40	40	41	67	66	46	53
Plant, Property, & Equipment, net	33	50	60	73	90	105	116	127	149	191	186
Total Noncurrent Assets	365	455	676	706	920	1,266	1,704	1,656	1,645	1,891	1,635
Long-Term Investments	-	-	-	-	59	62	61	64	61	69	72
Goodwill	154	205	342	341	439	596	864	892	935	1,112	897
Intangible Assets	153	175	246	227	326	398	565	514	477	474	381
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	-	-	0.00	26
Other Noncurrent Operating Assets	39	48	58	74	96	210	213	184	172	237	258
Total Liabilities & Shareholders' Equity	681	880	1,187	1,254	1,493	1,932	2,354	3,132	2,888	2,924	2,416
Total Liabilities	424	533	737	691	854	1,195	1,534	1,970	1,845	2,093	1,709
Total Current Liabilities	178	251	275	265	307	378	423	969	858	656	546
Accounts Payable	79	119	138	130	150	156	168	425	476	344	184
Current Employee Benefit Liabilities	68	84	108	121	135	171	213	354	333	279	288
Other Current Liabilities	2.63	5.37	17	5.15	10	39	26	174	48	34	74
Total Noncurrent Liabilities	246	282	463	426	546	817	1,111	1,000	987	1,437	1,163
Long-Term Debt	136	181	359	320	441	617	858	842	844	1,305	1,056
Noncurrent Deferred & Payable Income Tax Liabilities	32	22	21	27	27	47	67	48	23	23	0.00
Other Noncurrent Operating Liabilities	78	78	82	79	79	153	186	110	121	109	107
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	257	348	449	563	639	737	820	1,162	1,044	831	707
Total Preferred & Common Equity	257	348	449	563	639	737	820	1,162	1,044	831	707
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	257	348	449	563	639	737	820	1,162	1,044	831	707
Common Stock	435	444	453	454	453	456	469	487	502	507	529
Retained Earnings	-178	-96	9.67	142	286	400	470	797	1,241	1,452	1,305
Treasury Stock	-	0.00	-13	-33	-100	-119	-119	-122	-699	-1,127	-1,127
Accumulated Other Comprehensive Income / (Loss)	-0.36	-0.18	0.00	-0.11	0.15	0.15	0.04	-0.30	-0.94	-0.42	-0.01

This table presents AMN Healthcare Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	3,018	2,881	2,644	2,655	2,874	2,771	2,668
Total Current Assets	1,206	1,071	807	831	791	705	612
Cash & Equivalents	156	29	7.01	29	51	48	31
Accounts Receivable	979	964	748	742	676	590	520
Prepaid Expenses	17	27	18	18	25	20	17
Other Current Assets	55	52	34	42	39	47	45
Plant, Property, & Equipment, net	141	155	177	188	195	197	197
Total Noncurrent Assets	1,671	1,655	1,659	1,636	1,888	1,870	1,859
Long-Term Investments	65	68	72	70	72	72	72
Goodwill	936	935	936	936	1,115	1,116	1,117
Intangible Assets	499	454	432	410	449	425	402
Other Noncurrent Operating Assets	171	197	220	221	252	257	267
Total Liabilities & Shareholders' Equity	3,018	2,881	2,644	2,655	2,874	2,771	2,668
Total Liabilities	1,886	1,925	1,878	1,838	2,019	1,894	1,777
Total Current Liabilities	891	804	674	707	624	574	519
Accounts Payable	459	474	328	363	316	283	213
Current Employee Benefit Liabilities	339	269	262	264	281	268	282
Other Current Liabilities	78	61	85	81	27	22	24
Total Noncurrent Liabilities	994	1,122	1,204	1,130	1,396	1,321	1,259
Long-Term Debt	843	984	1,034	939	1,270	1,190	1,131
Noncurrent Deferred & Payable Income Tax Liabilities	42	16	6.99	31	15	21	17
Other Noncurrent Operating Liabilities	109	122	163	160	110	110	111
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,133	956	766	817	854	877	891
Total Preferred & Common Equity	1,133	956	766	817	854	877	891
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,133	956	766	817	854	877	891
Common Stock	498	506	468	506	513	519	526
Retained Earnings	1,159	1,325	1,386	1,439	1,469	1,485	1,492
Treasury Stock	-524	-875	-1,087	-1,127	-1,127	-1,127	-1,127
Accumulated Other Comprehensive Income / (Loss)	-1.09	-0.79	-0.74	-0.61	-0.34	-0.16	-0.06

This table displays calculated financial ratios and metrics derived from AMN Healthcare Services' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.39%	41.22%	30.02%	4.53%	7.42%	4.03%	7.72%	66.45%	31.60%	-27.73%	-21.26%
EBITDA Growth	6.13%	78.59%	47.67%	10.55%	-0.30%	-3.58%	3.54%	138.94%	34.82%	-36.32%	-85.76%
EBIT Growth	3.67%	89.80%	48.69%	10.86%	-4.52%	-12.78%	-15.63%	220.23%	35.38%	-47.70%	-130.34%
NOPAT Growth	-0.48%	126.70%	32.09%	26.89%	5.41%	-11.81%	-15.14%	205.88%	34.35%	-47.05%	-128.66%
Net Income Growth	0.86%	146.53%	29.24%	25.25%	6.93%	-19.58%	-38.01%	363.30%	35.63%	-52.56%	-169.76%
EPS Growth	0.00%	143.48%	27.98%	24.65%	8.58%	-17.53%	-38.33%	360.14%	45.37%	-45.86%	-171.83%
Operating Cash Flow Growth	-54.00%	103.46%	137.79%	19.87%	41.41%	-0.94%	14.21%	18.90%	114.09%	-43.07%	-13.90%
Free Cash Flow Firm Growth	-153.81%	-537.28%	-120.31%	190.25%	-143.58%	-34.38%	-302.51%	169.22%	154.20%	-104.66%	1,385.11%
Invested Capital Growth	14.04%	37.47%	45.52%	4.22%	25.35%	20.10%	31.69%	10.50%	0.14%	15.49%	-17.41%
Revenue Q/Q Growth	3.08%	9.17%	4.70%	1.08%	0.92%	2.69%	1.89%	22.50%	-4.33%	-7.50%	-2.72%
EBITDA Q/Q Growth	4.10%	14.19%	7.71%	1.75%	-0.08%	1.05%	-4.36%	32.79%	-4.75%	-13.81%	-77.02%
EBIT Q/Q Growth	4.50%	15.58%	7.54%	1.64%	-1.47%	-1.78%	-10.93%	41.39%	-7.08%	-20.09%	-176.59%
NOPAT Q/Q Growth	3.17%	13.92%	8.36%	11.43%	-6.19%	-0.74%	-4.27%	37.68%	-6.48%	-20.10%	-167.82%
Net Income Q/Q Growth	4.86%	14.34%	6.21%	12.58%	-3.77%	-6.66%	-20.46%	48.49%	-7.19%	-24.75%	-377.09%
EPS Q/Q Growth	4.55%	15.07%	5.91%	12.13%	-3.32%	-5.51%	-21.28%	48.37%	-4.53%	-22.32%	-365.52%
Operating Cash Flow Q/Q Growth	-27.76%	-7.41%	56.63%	6.17%	0.23%	9.61%	-13.13%	14.27%	6.06%	-29.60%	55.19%
Free Cash Flow Firm Q/Q Growth	56.33%	6.15%	25.81%	5.63%	-9.84%	13.55%	-6.92%	13.12%	8.30%	-105.33%	281.70%
Invested Capital Q/Q Growth	6.69%	6.23%	-0.50%	0.63%	-0.07%	-0.99%	0.01%	4.46%	0.35%	22.75%	-12.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.51%	32.08%	32.58%	32.41%	32.60%	33.46%	33.08%	32.87%	32.74%	32.98%	30.81%
EBITDA Margin	8.10%	10.24%	11.63%	12.30%	11.42%	10.58%	10.17%	14.60%	14.96%	13.18%	2.38%
Operating Margin	6.55%	8.81%	10.07%	10.68%	9.50%	7.96%	6.24%	12.00%	12.34%	8.93%	-3.44%
EBIT Margin	6.55%	8.81%	10.07%	10.68%	9.50%	7.96%	6.24%	12.00%	12.34%	8.93%	-3.44%
Profit (Net Income) Margin	3.21%	5.60%	5.56%	6.67%	6.64%	5.13%	2.95%	8.22%	8.47%	5.56%	-4.93%
Tax Burden Percent	56.62%	67.63%	60.08%	68.77%	75.93%	76.77%	77.21%	73.75%	73.19%	74.11%	85.17%
Interest Burden Percent	86.40%	93.96%	91.93%	90.74%	92.04%	83.93%	61.32%	92.87%	93.76%	84.00%	168.08%
Effective Tax Rate	43.38%	32.37%	39.92%	31.23%	24.07%	23.23%	22.79%	26.25%	26.81%	25.89%	0.00%
Return on Invested Capital (ROIC)	10.64%	19.06%	17.71%	18.57%	17.02%	12.26%	8.23%	21.04%	26.91%	13.22%	-3.87%
ROIC Less NNEP Spread (ROIC-NNEP)	6.43%	15.66%	14.02%	13.75%	12.99%	7.06%	1.06%	17.37%	22.41%	9.04%	-10.77%
Return on Net Nonoperating Assets (RNNOA)	3.37%	8.04%	8.84%	7.63%	6.57%	4.31%	0.85%	12.00%	13.36%	9.26%	-15.24%
Return on Equity (ROE)	14.01%	27.10%	26.55%	26.20%	23.59%	16.57%	9.08%	33.04%	40.26%	22.47%	-19.11%
Cash Return on Invested Capital (CROIC)	-2.48%	-12.49%	-19.37%	14.44%	-5.47%	-6.01%	-19.12%	11.06%	26.77%	-1.16%	15.20%
Operating Return on Assets (OROA)	10.57%	16.51%	18.54%	17.41%	14.77%	10.33%	6.97%	17.43%	21.50%	11.64%	-3.85%
Return on Assets (ROA)	5.17%	10.49%	10.24%	10.86%	10.32%	6.66%	3.30%	11.94%	14.75%	7.25%	-5.50%
Return on Common Equity (ROCE)	14.01%	27.10%	26.55%	26.20%	23.59%	16.57%	9.08%	33.04%	40.26%	22.47%	-19.11%
Return on Equity Simple (ROE_SIMPLE)	12.95%	23.54%	23.55%	23.56%	22.18%	15.47%	8.62%	28.17%	42.55%	25.34%	-20.80%
Net Operating Profit after Tax (NOPAT)	38	87	115	146	154	136	115	353	474	251	-72
NOPAT Margin	3.71%	5.96%	6.05%	7.35%	7.21%	6.11%	4.81%	8.85%	9.03%	6.62%	-2.41%
Net Nonoperating Expense Percent (NNEP)	4.21%	3.40%	3.70%	4.82%	4.03%	5.20%	7.17%	3.67%	4.50%	4.18%	6.90%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	25.10%	11.74%	-4.08%
Cost of Revenue to Revenue	69.49%	67.92%	67.42%	67.59%	67.40%	66.54%	66.92%	67.13%	67.26%	67.02%	69.19%
SG&A Expenses to Revenue	22.41%	21.84%	20.95%	20.10%	21.18%	22.86%	22.97%	18.33%	17.86%	19.96%	21.20%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.96%	23.27%	22.50%	21.72%	23.11%	25.50%	26.84%	20.87%	20.40%	24.05%	34.25%
Earnings before Interest and Taxes (EBIT)	68	129	192	212	203	177	149	478	647	338	-103
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	84	150	221	245	244	235	243	582	784	499	71
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.56	4.26	4.11	4.18	4.16	3.95	3.92	4.98	4.27	3.40	1.29
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.88	1.01	0.97	1.18	1.24	1.31	1.34	1.45	0.85	0.75	0.31
Price to Earnings (P/E)	27.40	18.05	17.43	17.76	18.70	25.53	45.50	17.68	10.05	13.40	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.65%	5.54%	5.74%	5.63%	5.35%	3.92%	2.20%	5.66%	9.95%	7.46%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.76	3.19	2.86	3.31	3.00	2.80	2.50	3.63	2.94	1.98	1.12
Enterprise Value to Revenue (EV/Rev)	1.03	1.16	1.16	1.34	1.42	1.52	1.66	1.60	0.99	1.06	0.63
Enterprise Value to EBITDA (EV/EBITDA)	12.66	11.28	9.94	10.87	12.40	14.39	16.36	10.97	6.60	8.08	26.50
Enterprise Value to EBIT (EV/EBIT)	15.64	13.11	11.48	12.51	14.90	19.12	26.68	13.35	8.00	11.92	0.00
Enterprise Value to NOPAT (EV/NOPAT)	27.63	19.39	19.11	18.19	19.63	24.91	34.55	18.10	10.92	16.08	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	38.37	30.01	16.43	16.56	13.32	15.04	15.50	20.89	7.91	10.84	5.88
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	23.39	0.00	0.00	0.00	34.42	10.98	0.00	6.67
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.63	0.63	0.81	0.57	0.69	0.84	1.05	0.72	0.81	1.57	1.49
Long-Term Debt to Equity	0.53	0.52	0.80	0.57	0.69	0.84	1.05	0.72	0.81	1.57	1.49
Financial Leverage	0.52	0.51	0.63	0.55	0.51	0.61	0.80	0.69	0.60	1.02	1.42
Leverage Ratio	2.71	2.58	2.59	2.41	2.29	2.49	2.75	2.77	2.73	3.10	3.47
Compound Leverage Factor	2.34	2.43	2.38	2.19	2.10	2.09	1.69	2.57	2.56	2.60	5.84
Debt to Total Capital	38.58%	38.58%	44.68%	36.25%	40.81%	45.58%	51.28%	42.02%	44.70%	61.08%	59.91%
Short-Term Debt to Total Capital	6.10%	6.62%	0.46%	0.00%	0.00%	0.00%	0.28%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	32.48%	31.96%	44.22%	36.25%	40.81%	45.58%	51.00%	42.02%	44.70%	61.08%	59.91%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	61.42%	61.42%	55.32%	63.75%	59.19%	54.42%	48.72%	57.98%	55.30%	38.92%	40.09%
Debt to EBITDA	1.92	1.46	1.64	1.31	1.81	2.62	3.54	1.45	1.08	2.61	14.85
Net Debt to EBITDA	1.77	1.39	1.59	1.25	1.51	2.01	3.17	1.03	0.92	2.41	13.69
Long-Term Debt to EBITDA	1.62	1.21	1.62	1.31	1.81	2.62	3.52	1.45	1.08	2.61	14.85
Debt to NOPAT	4.19	2.51	3.15	2.19	2.86	4.54	7.49	2.39	1.78	5.20	-14.69
Net Debt to NOPAT	3.85	2.40	3.06	2.09	2.39	3.48	6.70	1.69	1.52	4.80	-13.54
Long-Term Debt to NOPAT	3.53	2.08	3.12	2.19	2.86	4.54	7.44	2.39	1.78	5.20	-14.69
Altman Z-Score	2.96	3.83	3.83	4.55	4.15	3.32	2.82	4.04	4.70	3.26	2.20
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.59	1.50	1.64	1.79	1.57	1.48	1.26	1.39	1.27	1.28	1.09
Quick Ratio	1.28	1.35	1.46	1.53	1.40	1.34	1.13	1.25	1.18	1.18	0.95
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-8.96	-57	-126	114	-50	-67	-268	185	471	-22	282
Operating Cash Flow to CapEx	144.65%	208.49%	609.90%	605.07%	644.76%	638.49%	681.20%	569.98%	862.09%	358.93%	396.11%
Free Cash Flow to Firm to Interest Expense	-0.97	-7.33	-8.14	5.77	-3.07	-2.34	-4.64	5.44	11.66	-0.41	4.04
Operating Cash Flow to Interest Expense	3.00	7.23	8.66	8.16	14.06	7.91	4.45	8.96	16.18	6.87	4.58
Operating Cash Flow Less CapEx to Interest Expense	0.93	3.76	7.24	6.81	11.88	6.67	3.79	7.39	14.31	4.96	3.43
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.61	1.87	1.84	1.63	1.56	1.30	1.12	1.45	1.74	1.30	1.12
Accounts Receivable Turnover	5.45	5.38	5.28	5.08	5.29	5.28	5.47	5.39	5.31	4.50	4.78
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	38.34	35.25	34.56	29.82	26.07	22.76	21.66	32.75	37.94	22.25	15.80
Accounts Payable Turnover	9.58	10.05	10.01	10.04	10.29	9.67	9.89	9.02	7.82	6.19	7.82
Days Sales Outstanding (DSO)	67.02	67.80	69.08	71.84	68.99	69.10	66.75	67.74	68.68	81.18	76.42
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	38.10	36.33	36.48	36.37	35.48	37.74	36.91	40.47	46.66	58.95	46.69
Cash Conversion Cycle (CCC)	28.92	31.47	32.60	35.47	33.51	31.37	29.83	27.27	22.02	22.23	29.73
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	385	529	770	803	1,006	1,209	1,592	1,759	1,761	2,034	1,680
Invested Capital Turnover	2.87	3.20	2.93	2.53	2.36	2.01	1.71	2.38	2.98	2.00	1.61
Increase / (Decrease) in Invested Capital	47	144	241	32	204	202	383	167	2.46	273	-354
Enterprise Value (EV)	1,062	1,690	2,200	2,657	3,023	3,383	3,982	6,380	5,174	4,033	1,884
Market Capitalization	914	1,481	1,848	2,353	2,656	2,911	3,210	5,783	4,456	2,830	911
Book Value per Share	$5.50	$7.29	$9.35	$11.78	$13.63	$15.77	$17.43	$24.58	$24.08	$22.00	$18.56
Tangible Book Value per Share	($1.08)	($0.67)	($2.87)	($0.11)	($2.68)	($5.51)	($12.96)	($5.18)	($8.50)	($19.96)	($15.03)
Total Capital	418	566	812	882	1,080	1,354	1,682	2,004	1,887	2,136	1,762
Total Debt	161	218	363	320	441	617	863	842	844	1,305	1,056
Total Long-Term Debt	136	181	359	320	441	617	858	842	844	1,305	1,056
Net Debt	148	209	352	305	367	472	772	597	718	1,203	973
Capital Expenditures (CapEx)	19	27	22	27	35	35	38	54	76	104	81
Debt-free, Cash-free Net Working Capital (DFCFNWC)	117	153	169	194	161	99	86	199	171	153	38
Debt-free Net Working Capital (DFNWC)	130	162	180	209	175	182	115	380	236	186	49
Net Working Capital (NWC)	104	125	176	209	175	182	111	380	236	186	49
Net Nonoperating Expense (NNE)	5.23	5.27	9.29	14	12	22	45	25	30	40	75
Net Nonoperating Obligations (NNO)	129	182	321	240	367	472	772	597	718	1,203	973
Total Depreciation and Amortization (D&A)	16	21	30	32	41	58	94	104	137	161	174
Debt-free, Cash-free Net Working Capital to Revenue	11.27%	10.43%	8.88%	9.74%	7.54%	4.47%	3.60%	4.99%	3.26%	4.03%	1.29%
Debt-free Net Working Capital to Revenue	12.54%	11.08%	9.44%	10.50%	8.19%	8.21%	4.82%	9.53%	4.50%	4.90%	1.65%
Net Working Capital to Revenue	10.07%	8.52%	9.24%	10.50%	8.19%	8.21%	4.63%	9.53%	4.50%	4.90%	1.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.71	$1.72	$2.21	$2.77	$2.99	$2.44	$1.49	$6.87	$9.96	$5.38	($3.85)
Adjusted Weighted Average Basic Shares Outstanding	46.50M	47.53M	47.95M	47.81M	47.37M	46.70M	47.42M	47.69M	44.59M	39.17M	38.19M
Adjusted Diluted Earnings per Share	$0.69	$1.68	$2.15	$2.68	$2.91	$2.40	$1.48	$6.81	$9.90	$5.36	($3.85)
Adjusted Weighted Average Diluted Shares Outstanding	48.09M	48.84M	49.27M	49.43M	48.67M	47.59M	47.69M	48.05M	44.87M	39.34M	38.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	46.50M	47.53M	47.72M	47.66M	46.87M	46.85M	47.18M	46.64M	44.59M	37.89M	38.19M
Normalized Net Operating Profit after Tax (NOPAT)	38	87	115	146	154	136	115	353	474	251	84
Normalized NOPAT Margin	3.71%	5.96%	6.05%	7.35%	7.21%	6.11%	4.81%	8.85%	9.03%	6.62%	2.81%
Pre Tax Income Margin	5.66%	8.28%	9.26%	9.69%	8.74%	6.68%	3.82%	11.14%	11.57%	7.50%	-5.78%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.35	16.54	12.39	10.80	12.56	6.22	2.59	14.03	16.02	6.25	-1.47
NOPAT to Interest Expense	4.16	11.19	7.44	7.42	9.54	4.78	2.00	10.34	11.72	4.63	-1.03
EBIT Less CapEx to Interest Expense	5.28	13.08	10.97	9.45	10.38	4.98	1.93	12.45	14.14	4.34	-2.63
NOPAT Less CapEx to Interest Expense	2.09	7.72	6.02	6.08	7.36	3.54	1.34	8.77	9.85	2.72	-2.19
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	12.53%	15.21%	47.28%	16.41%	0.00%	0.82%	129.89%	201.61%	0.00%

This table displays calculated financial ratios and metrics derived from AMN Healthcare Services' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	29.71%	-17.43%	-27.46%	-30.51%	-25.04%	-27.30%	-27.11%	-25.28%	-19.44%	-10.21%
EBITDA Growth	28.71%	-19.92%	-31.30%	-40.08%	-25.22%	-50.85%	-48.66%	-36.55%	-48.84%	-308.37%
EBIT Growth	28.86%	-29.26%	-39.56%	-50.06%	-36.26%	-71.35%	-68.21%	-58.89%	-74.40%	-692.78%
NOPAT Growth	27.07%	-26.45%	-40.17%	-46.38%	-38.03%	-66.42%	-67.59%	-60.34%	-67.52%	-565.31%
Net Income Growth	24.89%	-29.62%	-42.39%	-50.80%	-42.48%	-84.73%	-79.40%	-73.34%	-86.86%	-1,601.59%
EPS Growth	36.36%	-19.50%	-34.63%	-44.04%	-33.81%	-79.38%	-77.72%	-72.90%	-87.05%	-1,325.00%
Operating Cash Flow Growth	579.14%	47.88%	-78.31%	-11.94%	51.41%	-135.66%	87.38%	-49.66%	-61.26%	277.03%
Free Cash Flow Firm Growth	292.39%	301.66%	-113.13%	1,897.06%	478.00%	-374.42%	-1,566.41%	-320.69%	-251.49%	187.65%
Invested Capital Growth	4.24%	0.14%	5.69%	-1.11%	-5.59%	15.49%	8.58%	13.10%	15.77%	-17.41%
Revenue Q/Q Growth	-20.19%	-1.15%	0.06%	-11.98%	-13.90%	-4.12%	0.32%	-9.77%	-7.18%	6.87%
EBITDA Q/Q Growth	-21.26%	-7.85%	4.59%	-21.04%	-1.73%	-39.44%	9.26%	-2.42%	-20.77%	-346.67%
EBIT Q/Q Growth	-25.70%	-12.54%	5.37%	-27.06%	-5.17%	-60.69%	16.90%	-5.67%	-40.95%	-1,010.26%
NOPAT Q/Q Growth	-24.46%	-8.28%	0.92%	-23.31%	-12.70%	-50.30%	-2.58%	-6.17%	-28.49%	-811.85%
Net Income Q/Q Growth	-25.33%	-11.52%	2.83%	-27.59%	-12.70%	-76.51%	38.75%	-6.30%	-56.96%	-2,783.26%
EPS Q/Q Growth	-24.19%	-7.62%	4.12%	-23.27%	-10.32%	-71.22%	12.50%	-6.67%	-57.14%	-2,822.22%
Operating Cash Flow Q/Q Growth	-49.33%	1.41%	-62.34%	355.10%	-12.89%	-123.89%	297.88%	22.28%	-32.97%	9.16%
Free Cash Flow Firm Q/Q Growth	653.13%	220.24%	-108.74%	1,261.14%	77.91%	-252.04%	46.94%	-53.78%	-22.12%	187.97%
Invested Capital Q/Q Growth	0.81%	0.35%	4.66%	-6.60%	-3.75%	22.75%	-1.60%	-2.72%	-1.48%	-12.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.82%	33.34%	32.75%	33.32%	33.92%	31.89%	31.37%	31.03%	30.99%	29.81%
EBITDA Margin	14.99%	13.98%	14.61%	13.10%	14.96%	9.45%	10.29%	11.13%	9.50%	-21.92%
Operating Margin	11.98%	10.60%	11.16%	9.25%	10.19%	4.18%	4.87%	5.09%	3.24%	-27.57%
EBIT Margin	11.98%	10.60%	11.16%	9.25%	10.19%	4.18%	4.87%	5.09%	3.24%	-27.57%
Profit (Net Income) Margin	8.12%	7.27%	7.47%	6.14%	6.23%	1.53%	2.11%	2.19%	1.02%	-25.52%
Tax Burden Percent	72.56%	76.09%	72.88%	76.62%	70.54%	89.18%	74.31%	73.92%	89.51%	83.10%
Interest Burden Percent	93.43%	90.13%	91.84%	86.72%	86.72%	40.99%	58.37%	58.30%	35.09%	111.41%
Effective Tax Rate	27.44%	23.91%	27.12%	23.38%	29.46%	10.82%	25.69%	26.08%	10.49%	0.00%
Return on Invested Capital (ROIC)	27.70%	24.02%	21.84%	17.93%	17.25%	7.44%	6.55%	6.63%	4.97%	-31.01%
ROIC Less NNEP Spread (ROIC-NNEP)	26.67%	22.66%	20.87%	16.80%	16.14%	5.56%	5.34%	5.48%	3.59%	-35.21%
Return on Net Nonoperating Assets (RNNOA)	15.50%	13.50%	15.89%	15.42%	12.10%	5.70%	6.00%	6.76%	3.92%	-49.83%
Return on Equity (ROE)	43.20%	37.52%	37.73%	33.35%	29.35%	13.13%	12.56%	13.39%	8.89%	-80.83%
Cash Return on Invested Capital (CROIC)	25.30%	26.77%	17.44%	21.41%	24.14%	-1.16%	1.61%	-4.31%	-8.69%	15.20%
Operating Return on Assets (OROA)	22.92%	18.46%	17.54%	14.33%	14.71%	5.44%	5.89%	6.07%	3.73%	-30.81%
Return on Assets (ROA)	15.54%	12.66%	11.74%	9.52%	9.00%	1.99%	2.56%	2.62%	1.17%	-28.52%
Return on Common Equity (ROCE)	43.20%	37.52%	37.73%	33.35%	29.35%	13.13%	12.56%	13.39%	8.89%	-80.83%
Return on Equity Simple (ROE_SIMPLE)	42.24%	0.00%	39.98%	41.66%	34.26%	0.00%	16.85%	11.32%	5.96%	0.00%
Net Operating Profit after Tax (NOPAT)	99	91	92	70	61	30	30	28	20	-142
NOPAT Margin	8.69%	8.06%	8.13%	7.09%	7.18%	3.72%	3.62%	3.76%	2.90%	-19.30%
Net Nonoperating Expense Percent (NNEP)	1.03%	1.36%	0.96%	1.13%	1.11%	1.87%	1.21%	1.15%	1.38%	4.20%
Return On Investment Capital (ROIC_SIMPLE)	-	4.81%	-	-	-	1.43%	-	-	-	-8.04%
Cost of Revenue to Revenue	66.18%	66.66%	67.25%	66.68%	66.08%	68.11%	68.63%	68.97%	69.01%	70.19%
SG&A Expenses to Revenue	18.92%	19.47%	18.26%	20.35%	19.15%	22.67%	21.30%	20.12%	21.77%	21.63%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.84%	22.74%	21.59%	24.07%	23.74%	27.71%	26.50%	25.94%	27.75%	57.38%
Earnings before Interest and Taxes (EBIT)	136	119	126	92	87	34	40	38	22	-203
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	171	157	165	130	128	77	84	82	65	-161
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.05	4.27	3.56	5.65	3.96	3.40	2.77	2.22	1.81	1.29
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.84	0.85	0.71	0.99	0.79	0.75	0.68	0.60	0.53	0.31
Price to Earnings (P/E)	9.61	10.05	8.91	13.55	11.54	13.40	16.36	19.50	30.06	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	10.41%	9.95%	11.23%	7.38%	8.67%	7.46%	6.11%	5.13%	3.33%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.97	2.94	2.33	3.07	2.46	1.98	1.75	1.55	1.38	1.12
Enterprise Value to Revenue (EV/Rev)	0.95	0.99	0.89	1.21	1.00	1.06	1.01	0.93	0.86	0.63
Enterprise Value to EBITDA (EV/EBITDA)	6.33	6.60	6.05	8.49	7.04	8.08	8.37	8.11	8.53	26.50
Enterprise Value to EBIT (EV/EBIT)	7.48	8.00	7.60	11.17	9.62	11.92	13.89	15.18	19.69	0.00
Enterprise Value to NOPAT (EV/NOPAT)	10.28	10.92	10.42	15.03	12.99	16.08	18.55	20.61	24.90	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	8.45	7.91	8.64	11.23	7.71	10.84	8.56	9.67	12.78	5.88
Enterprise Value to Free Cash Flow (EV/FCFF)	11.97	10.98	13.73	14.25	9.89	0.00	113.35	0.00	0.00	6.67
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.74	0.81	1.03	1.35	1.15	1.57	1.49	1.36	1.27	1.49
Long-Term Debt to Equity	0.74	0.81	1.03	1.35	1.15	1.57	1.49	1.36	1.27	1.49
Financial Leverage	0.58	0.60	0.76	0.92	0.75	1.02	1.12	1.23	1.09	1.42
Leverage Ratio	2.63	2.73	3.01	3.13	2.91	3.10	3.18	3.30	3.12	3.47
Compound Leverage Factor	2.46	2.46	2.76	2.71	2.52	1.27	1.86	1.92	1.09	3.87
Debt to Total Capital	42.68%	44.70%	50.72%	57.44%	53.48%	61.08%	59.79%	57.58%	55.93%	59.91%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	42.68%	44.70%	50.72%	57.44%	53.48%	61.08%	59.79%	57.58%	55.93%	59.91%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	57.32%	55.30%	49.28%	42.56%	46.52%	38.92%	40.21%	42.42%	44.07%	40.09%
Debt to EBITDA	1.02	1.08	1.39	1.66	1.62	2.61	3.03	3.20	3.65	14.85
Net Debt to EBITDA	0.76	0.92	1.25	1.54	1.45	2.41	2.74	2.88	3.32	13.69
Long-Term Debt to EBITDA	1.02	1.08	1.39	1.66	1.62	2.61	3.03	3.20	3.65	14.85
Debt to NOPAT	1.67	1.78	2.39	2.94	2.99	5.20	6.71	8.13	10.67	-14.69
Net Debt to NOPAT	1.23	1.52	2.15	2.72	2.68	4.80	6.07	7.31	9.70	-13.54
Long-Term Debt to NOPAT	1.67	1.78	2.39	2.94	2.99	5.20	6.71	8.13	10.67	-14.69
Altman Z-Score	4.09	4.10	3.63	3.95	3.52	2.92	2.75	2.64	2.55	2.06
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.35	1.27	1.33	1.20	1.18	1.28	1.27	1.23	1.18	1.09
Quick Ratio	1.27	1.18	1.24	1.12	1.09	1.18	1.16	1.11	1.06	0.95
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	28	88	-7.71	90	159	-242	-129	-198	-241	212
Operating Cash Flow to CapEx	557.00%	468.77%	248.38%	747.35%	576.00%	-137.76%	448.53%	364.98%	346.33%	448.91%
Free Cash Flow to Firm to Interest Expense	3.08	7.50	-0.75	7.36	13.81	-12.02	-7.73	-12.58	-16.71	9.19
Operating Cash Flow to Interest Expense	12.69	9.80	4.23	16.24	14.92	-2.04	4.89	6.33	4.62	3.15
Operating Cash Flow Less CapEx to Interest Expense	10.41	7.71	2.53	14.06	12.33	-3.52	3.80	4.60	3.28	2.45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.91	1.74	1.57	1.55	1.44	1.30	1.21	1.19	1.15	1.12
Accounts Receivable Turnover	6.48	5.31	4.31	4.93	4.76	4.50	4.25	4.83	4.86	4.78
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	40.79	37.94	33.81	27.92	24.94	22.25	19.92	17.27	15.96	15.80
Accounts Payable Turnover	9.97	7.82	6.65	7.43	6.65	6.19	5.94	7.19	7.31	7.82
Days Sales Outstanding (DSO)	56.30	68.68	84.65	74.03	76.65	81.18	85.93	75.54	75.05	76.42
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	36.61	46.66	54.91	49.12	54.91	58.95	61.45	50.77	49.92	46.69
Cash Conversion Cycle (CCC)	19.68	22.02	29.74	24.91	21.75	22.23	24.49	24.78	25.12	29.73
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,755	1,761	1,843	1,722	1,657	2,034	2,002	1,947	1,919	1,680
Invested Capital Turnover	3.19	2.98	2.69	2.53	2.40	2.00	1.81	1.76	1.72	1.61
Increase / (Decrease) in Invested Capital	71	2.46	99	-19	-98	273	158	226	261	-354
Enterprise Value (EV)	5,208	5,174	4,295	5,282	4,076	4,033	3,510	3,017	2,639	1,884
Market Capitalization	4,585	4,456	3,407	4,326	3,236	2,830	2,362	1,947	1,611	911
Book Value per Share	$26.17	$24.08	$23.27	$19.33	$21.51	$22.00	$22.41	$23.08	$23.44	$18.56
Tangible Book Value per Share	($6.98)	($8.50)	($10.57)	($15.18)	($13.91)	($19.96)	($18.62)	($17.47)	($16.54)	($15.03)
Total Capital	1,976	1,887	1,940	1,800	1,757	2,136	2,124	2,067	2,021	1,762
Total Debt	843	844	984	1,034	939	1,305	1,270	1,190	1,131	1,056
Total Long-Term Debt	843	844	984	1,034	939	1,305	1,270	1,190	1,131	1,056
Net Debt	623	718	888	956	840	1,203	1,148	1,070	1,028	973
Capital Expenditures (CapEx)	20	25	17	26	30	30	18	27	19	16
Debt-free, Cash-free Net Working Capital (DFCFNWC)	159	171	239	127	95	153	116	83	63	38
Debt-free Net Working Capital (DFNWC)	315	236	267	134	124	186	167	131	94	49
Net Working Capital (NWC)	315	236	267	134	124	186	167	131	94	49
Net Nonoperating Expense (NNE)	6.50	8.95	7.48	9.33	8.14	18	12	12	13	46
Net Nonoperating Obligations (NNO)	623	718	888	956	840	1,203	1,148	1,070	1,028	973
Total Depreciation and Amortization (D&A)	34	38	39	38	41	43	45	45	43	41
Debt-free, Cash-free Net Working Capital to Revenue	2.90%	3.26%	4.96%	2.89%	2.31%	4.03%	3.34%	2.56%	2.06%	1.29%
Debt-free Net Working Capital to Revenue	5.75%	4.50%	5.55%	3.05%	3.03%	4.90%	4.79%	4.05%	3.06%	1.65%
Net Working Capital to Revenue	5.75%	4.50%	5.55%	3.05%	3.03%	4.90%	4.79%	4.05%	3.06%	1.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.11	$1.96	$2.03	$1.56	$1.39	$0.40	$0.45	$0.43	$0.18	($4.91)
Adjusted Weighted Average Basic Shares Outstanding	43.79M	44.59M	41.38M	39.15M	38.15M	39.17M	38.11M	38.17M	38.20M	38.19M
Adjusted Diluted Earnings per Share	$2.10	$1.94	$2.02	$1.55	$1.39	$0.40	$0.45	$0.42	$0.18	($4.90)
Adjusted Weighted Average Diluted Shares Outstanding	44.04M	44.87M	41.57M	39.34M	38.33M	39.34M	38.20M	38.23M	38.29M	38.19M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	43.34M	44.59M	39.65M	37.99M	37.79M	37.89M	38.00M	38.00M	38.07M	38.19M
Normalized Net Operating Profit after Tax (NOPAT)	99	91	92	70	61	30	30	28	20	-142
Normalized NOPAT Margin	8.69%	8.06%	8.13%	7.09%	7.18%	3.72%	3.62%	3.76%	2.90%	-19.30%
Pre Tax Income Margin	11.19%	9.55%	10.25%	8.02%	8.83%	1.71%	2.84%	2.97%	1.14%	-30.72%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	15.22	10.13	12.25	7.53	7.53	1.69	2.40	2.40	1.54	-8.76
NOPAT to Interest Expense	11.04	7.71	8.93	5.77	5.31	1.51	1.79	1.77	1.38	-6.13
EBIT Less CapEx to Interest Expense	12.94	8.04	10.55	5.36	4.94	0.21	1.31	0.66	0.21	-9.46
NOPAT Less CapEx to Interest Expense	8.76	5.62	7.22	3.60	2.72	0.03	0.69	0.04	0.05	-6.84
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	84.56%	129.89%	136.98%	187.82%	214.16%	201.61%	173.74%	0.00%	0.00%	0.00%

Frequently Asked Questions About AMN Healthcare Services' Financials

When does AMN Healthcare Services's financial year end?

According to the most recent income statement we have on file, AMN Healthcare Services' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has AMN Healthcare Services' net income changed over the last 10 years?

AMN Healthcare Services' net income appears to be on an upward trend, with a most recent value of -$146.98 million in 2024, falling from $33.22 million in 2014. The previous period was $210.68 million in 2023.

What is AMN Healthcare Services's operating income?

AMN Healthcare Services's total operating income in 2024 was -$102.67 million, based on the following breakdown:

Total Gross Profit: $919.38 million
Total Operating Expenses: $1.02 billion

How has AMN Healthcare Services revenue changed over the last 10 years?

Over the last 10 years, AMN Healthcare Services' total revenue changed from $1.04 billion in 2014 to $2.98 billion in 2024, a change of 188.0%.

How much debt does AMN Healthcare Services have?

AMN Healthcare Services' total liabilities were at $1.71 billion at the end of 2024, a 18.3% decrease from 2023, and a 302.9% increase since 2014.

How much cash does AMN Healthcare Services have?

In the past 10 years, AMN Healthcare Services' cash and equivalents has ranged from $9.58 million in 2015 to $180.93 million in 2021, and is currently $10.65 million as of their latest financial filing in 2024.

How has AMN Healthcare Services' book value per share changed over the last 10 years?

Over the last 10 years, AMN Healthcare Services' book value per share changed from 5.50 in 2014 to 18.56 in 2024, a change of 237.3%.

Remove Ads

Related Companies

This page (NYSE:AMN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AMN Healthcare Services (AMN) Financials

Frequently Asked Questions About AMN Healthcare Services' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AMN Healthcare Services (AMN) Financials

Annual Income Statements for AMN Healthcare Services

Quarterly Income Statements for AMN Healthcare Services

Annual Cash Flow Statements for AMN Healthcare Services

Quarterly Cash Flow Statements for AMN Healthcare Services

Annual Balance Sheets for AMN Healthcare Services

Quarterly Balance Sheets for AMN Healthcare Services

Annual Metrics and Ratios for AMN Healthcare Services

Quarterly Metrics and Ratios for AMN Healthcare Services

Frequently Asked Questions About AMN Healthcare Services' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools